Skip to main content
SpringerLink
Log in
Book cover

Praxis der Viszeralchirurgie pp 837–853Cite as

Urologie im Rahmen der Onkologischen Chirurgie — Diagnose und Therapie der häufigen urogenitalen Malignome

  • Chapter

  • 70 Accesses

Zusammenfassung

Die Urologie hat sich im 20. Jahrhundert aus einem Teilgebiet der Chirurgie als eigenständiges Fachgebiet etabliert. Dies war aufgrund der Entwicklung endoskopischer, spezifisch urologischer Operationsverfahren, der transurethralen Resektion sowie der perkutanen Nierensteinchirurgie notwendig geworden. Das Fachgebiet der Urologie beinhaltet heute alle Erkrankungen des Harntraktes beider Geschlechter wie auch der pädiatrischen Altersgruppen, mit Ausnahme der rein nephrologischen Erkrankungen, und die genitalen Erkrankungen und Funktionsstörungen des Mannes. Hierdurch ergeben sich Überschneidungen mit den Gebieten der inneren Medizin, der Gynäkologie, der Pädiatrie, der Dermatologie und der Chirurgie, mit letzterer in den Bereichen der Nebennierenerkrankungen, der Kinderchirurgie und der Transplantation. Im Bereich der urologischen Onkologie ist die kurative Therapie überwiegend aber nicht ausschließlich durch operative Therapieverfahren gekennzeichnet. Die Kenntnis der häufigen uroonkologischen Krankheitsbilder und ihrer Therapiemöglichkeiten ist aufgrund der zahlenmäßig großen Bedeutung dieser Erkrankungen für den Chirurgen wichtig.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Andriole GL, Smith DS, Rao G et al. (1994) Early complications of contemporary anatomical retropubic prostatectomy. J Urol 152: 1858–1860

    PubMed  CAS  Google Scholar 

  • Boyle P, Maisonneuve P, Evstifeeva T, Alexander FE (1994) What is the significance of trends in prostate cancer? IVth International Symposium on Recent Advances in Urological Cancer Diagnosis and Treatment. Paris, SCI Jersey

    Google Scholar 

  • Challen C, Mellon K, Neal DE, Lunec J (1993) p53 mutations in human bladder cancer: Association with smoking and poor prognosis. Br J Cancer 67 (Suppl XX): 58 (abstract)

    Google Scholar 

  • Coleman M, Esteve J, Damiecki P, Arslan A et al. (1993) Trends in cancer incidence and mortality. Lyon, International Agency for Research on Cancer

    Google Scholar 

  • Dexeus FH, Logothetis CJ, Sella A et al. (1991) Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 146: 1284–1287

    PubMed  CAS  Google Scholar 

  • Donohue JP, Thornhill JA, Foster RS et al. (1995) The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: The Indiana University experience (1965–1989). J Urol 153: 85–89

    Article  PubMed  CAS  Google Scholar 

  • Epstein JI, Partin AW, Sauvageot J, Walsh PC (1996) Prediction of progression following radical prostatectomy. Am J Surg Pathol 20: 286–292

    Article  PubMed  CAS  Google Scholar 

  • Fair WR, Fuks Z, Scher HI (1993) Cancer of the bladder. In: De-Vita VT, Hellman S, Rosenberg SA et al. (eds) Cancer: Principles and practice of oncology. Lippincott, Philadelphia, pp 1052–1072

    Google Scholar 

  • Ford D, Easton DF, Bishop DT et al. (1994) Risks of cancer in BRCA1 mutation carriers. Breast Cancer Linkage Consortium. Lancet 343: 692–695

    Google Scholar 

  • Fowler JE Jr, Braswell NT, Pandey P, Seaver L (1995) Experience with radical prostatectomy and radiation therapy for localized prostate cancer at a Veterans Affairs Medical Center. J Urol 153: 1026–1031

    Article  PubMed  Google Scholar 

  • Frazier HA, Rob erston JE, Paulson DF (1994) Does radical prostatectomy in the presence of positive lymph nodes enhance survival? World J Urol 12: 308–312

    Article  PubMed  Google Scholar 

  • Frohmüller HG, Wirth MP (1993) Adjuvant therapy after radi- cal prostatectomy. Recent Results Cancer Res 126: 51–57

    Article  PubMed  Google Scholar 

  • Frohmüller HGW, Theiss M, Manseck A, Wirth MP (1995) Survival and quality of life of patients with stage D1 (T 1–3,pN12,M0) prostate cancer. Radical prostatectomy plus androgen deprivation versus androgen deprivation alone. Eur Urol 27: 202–206

    Google Scholar 

  • Froschermaier SE, Pilarsky CP, Wirth MP (1996) Clinical significance of the determination of non-complexed prostate-specific antigen as a marker for prostate carcinoma. Urology 47: 525–528

    Article  PubMed  CAS  Google Scholar 

  • Gleason DF (1992) Histologic grading of prostate cancer: A perspective. Human Pathol 23: 273–279

    Article  CAS  Google Scholar 

  • Gospodarowicz MK, Warde P (1992) The role of radiation therapy in the management of transitional cell carcinoma of the bladder. Hematol Oncol Clin North Am 6: 147–168

    PubMed  CAS  Google Scholar 

  • Gronberg H, Isaacs SD, Smith Jr et al. (1997) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274: 1371–1373

    Google Scholar 

  • Hakenberg OW, Wirth MP (1997) Aktuelle Konzepte der Harnableitung nach radikaler Zystektomie. Der Onkologe 3: 254–264

    Article  Google Scholar 

  • Harding MJ, Paul J, Gillis CR, Kaye SB (1993) Management of malignant teratoma: Does referral to a specialist unit matter? Lancet 341: 999–1002

    Article  PubMed  CAS  Google Scholar 

  • Hartmann M, Dieckmann KP, Loy V (1998) Hodentumoren. In: Weißbach L, Miller K (Hrsg) Diagnostische und therapeutische Standards in der Urologischen Onkologie. München, Deutsche Krebsgesellschaft, S 65–91

    Google Scholar 

  • Hendry WF, A’Hern RP, Hetherington JW et al. (1993) Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: Prognostic value and therapeutic benefit. Br J Urol 71: 208–213

    Google Scholar 

  • Horwich A, Norman A, Fisher C et al. (1994) Primary chemotherapy for stage II nonseminomatous germ cell tumours of the testis. J Urol 151: 72–78

    PubMed  CAS  Google Scholar 

  • Huland H, Hühner D, Henke RP (1994) Systematic biopsies and digital rectal examination to identify the nerve-sparing side for radical prostatectomy without risk of positive margin in patients with clinical stage Ti, T2 NO prostatic carcinoma. Urology 44: 211–214

    Google Scholar 

  • Kupelian P, Katcher J, Levin H et al. (1996) Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Urology 48: 249–260

    Article  PubMed  CAS  Google Scholar 

  • Mathur VK, Krahn HP, Ramsey ED (1981) Total cystectomy for bladder cancer. J Urol 125: 784

    PubMed  CAS  Google Scholar 

  • McDougal WS, Kirchner FK Jr, Edwards RH, Killion LT (1986) Treatment of carcinoma of the penis: The case for primary lymphadenectomy. J Urol 151: 38–41

    Google Scholar 

  • Medical Research Council (1985) Prognostic factors in advanced non-seminomatous germ cell testicular tumours: Results of a multicentre study. Lancet 1: 8–11

    Google Scholar 

  • Messing EM, Catalona WJ (1998) Urothelial tumours of the urinary tract. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED Jr (eds) Campbell’s urology, vol 3, 7th edn. WB Saunders, Philadelphia, pp 1094–1158

    Google Scholar 

  • Nagpal BL, Prabhakar BR, Kataria SP et al. (1992) Male genital tract tumours in Punjab, India. J Environ Pathol Toxicol On-col 11: 331–334

    Google Scholar 

  • Ohori M, Goad JR, Wheeler TM et al. (1994) Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 152: 1843–1849

    PubMed  CAS  Google Scholar 

  • Ornellas AA, Seixas ALC, Marota A et al. (1994) Surgical treat-ment of invasive squamous cell carcinoma of the penis: Retrospective analysis of 350 cases. J Urol 151: 1244–1249

    PubMed  CAS  Google Scholar 

  • Ravi R (1993 a) Morbidity following groin dissection for penile carcinoma. Br J Urol 72: 941–945

    Google Scholar 

  • Ravi R (1993 b) Prophylactic lymphadenectomy vs observation vs inguinal biopsy in lymph-node negative patients with invasive carcinoma of the penis. Jpn J Clin Oncol 23: 53–58

    Google Scholar 

  • Ravi R, Dearnaley DP, Hendry WF (1998) Carcinoma of the penis. In: Whitfield HN, Hendry WF, Kirby RS, Duckett JW (eds) Textbook of genitourinary surgery, vol 2. Blackwell Science, Oxford, pp 1269–1278

    Google Scholar 

  • Skinner DG, Crawford ED, Kaufmann JJ (1982) Complications of radical cystectomy for carcinoma of the bladder. J Urol 123: 640

    Google Scholar 

  • Stephen RA (1962) The clinical presentation of testicular tumours. Br J Urol 34: 448–450

    Article  PubMed  CAS  Google Scholar 

  • Sternberg CN, Yagoda A, Herr HW et al. (1989) Methotrexate, vinblastine, doxorubicine and cisplatin for advanced transitional cell carcinoma of the urothelium: Efficacy and patterns of response and relapse. Cancer 64: 2448–2458

    Article  PubMed  CAS  Google Scholar 

  • Stöckle M, Meyenburg W, Welleck S et al. (1992) Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): Improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 148: 302–307

    Google Scholar 

  • Theiss M, Wirth MP, Manseck A, Frohmüller HG (1995) Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy. Prostate 27: 13–17

    Article  PubMed  CAS  Google Scholar 

  • Waterbor JW, Bueschen AJ (1995) Prostate cancer screening. Cancer Causes Control 6: 267–274

    Article  PubMed  CAS  Google Scholar 

  • Zietman AL, Coen JJ, Shipley WU et al. (1994) Radiation therapy in the management of prostatic adenocarcinoma: The initial prostate specific value as a predictor for treatment outcome. J Urol 151: 640–645

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. M. P. Wirth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. W. Hakenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chirurgische Klinik und Poliklinik, Technische Universität München, Ismaninger Straße 22, 81675, München, Deutschland

    J. R. Siewert

  2. Department für Chirurgie, Kantonsspital Basel, Spitalstraße 21, 4031, Basel, Schweiz

    F. Harder

  3. Klinik für Allgemeinchirurgie, Zentrum für Operative Medizin I, Baldingerstraße, 35043, Marburg, Deutschland

    M. Rothmund

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wirth, M.P., Hakenberg, O.W. (2001). Urologie im Rahmen der Onkologischen Chirurgie — Diagnose und Therapie der häufigen urogenitalen Malignome. In: Siewert, J.R., Harder, F., Rothmund, M. (eds) Praxis der Viszeralchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09420-4_45

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-09420-4_45

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-09421-1

  • Online ISBN: 978-3-662-09420-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation